BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8621362)

  • 1. A novel 1 beta-methylcarbapenem antibiotic, S-4661. Synthesis and structure-activity relationships of 2-(5-substituted pyrrolidin-3-ylthio)-1 beta-methylcarbapenems.
    Iso Y; Irie T; Nishino Y; Motokawa K; Nishitani Y
    J Antibiot (Tokyo); 1996 Feb; 49(2):199-209. PubMed ID: 8621362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1 beta-Methyl-2-(5-substituted pyrrolidin-3-ylthio)carbapenems. 3. Synthesis and antibacterial activity of BO-2727 and its related compounds.
    Ohtake N; Okamoto O; Mitomo R; Kato Y; Yamamoto K; Haga Y; Fukatsu H; Nakagawa S
    J Antibiot (Tokyo); 1997 Jul; 50(7):598-613. PubMed ID: 9711251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1 beta-Methyl-2(5-substituted pyrrolidin-3-ylthio)carbapenems. 1. Synthesis and antibacterial activity of BO-2502A and its related compounds.
    Ohtake N; Yamada K; Mano E; Okamoto O; Ushijima R; Nakagawa S
    J Antibiot (Tokyo); 1997 Jul; 50(7):567-85. PubMed ID: 9711249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1 beta-Methyl-2-(5-substituted pyrrolidin-3-ylthio)carbapenems. 2. Synthesis and antibacterial activity of 5-aminopropyl and 5-aminopropenyl pyrrolidine derivatives.
    Ohtake N; Okamoto O; Kato S; Ushijima R; Fukatsu H; Nakagawa S
    J Antibiot (Tokyo); 1997 Jul; 50(7):586-97. PubMed ID: 9711250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antibacterial evaluation of 1beta-methyl-2-[5-(1-methoxyimino-2-substituted sulfonamide ethyl)pyrrolidin-3-ylthio]carbapenems and their related compounds.
    Jeon H; Jo NH; Yoo KH; Choi JH; Cho H; Cho JH; Oh CH
    Eur J Med Chem; 2007 Mar; 42(3):358-64. PubMed ID: 17156896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antibacterial activity of 1 beta-methyl-2-(5-substituted imidazolino pyrrolidin-3-ylthio)carbapenem derivatives.
    Oh CH; Lee CS; Lee JS; Cho JH
    Arch Pharm (Weinheim); 2003 Nov; 336(11):504-9. PubMed ID: 14639742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the synthesis and structure-activity relationships of 2-(2-functionalized pyrrolidin-4-ylthio)-1 beta-methylcarbapenems.
    Lee HW; Kim EN; Son HJ; Ahn SK; Chung KH; Kim JW; Lee CR
    Chem Pharm Bull (Tokyo); 1996 Dec; 44(12):2326-30. PubMed ID: 8996864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of 1beta-methyl-2-[5-(N-substituted-2-hydroxy iminoethyl)pyrrolidin-3-ylthio]carbapenem derivatives.
    Oh CH; Lee SC; Cho JH
    Eur J Med Chem; 2003; 38(7-8):751-8. PubMed ID: 12932906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro activity of a series 1beta-methylcarbapenem derivatives.
    Jeon HC; Kim JW; Hong JH; Cho JH; Oh CH
    Eur J Med Chem; 2006 Oct; 41(10):1201-9. PubMed ID: 16797791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antibacterial evaluation of 1beta-methyl-2-(5-substituted heterocyclic carbamoyl)pyrrolidin-3-ylthio)carbapenem derivatives.
    Lee JS; Choa JH; Cho H; Oh CH
    Arch Pharm (Weinheim); 2004 Jul; 337(7):391-7. PubMed ID: 15237389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted thiazolo pyrrolidin-3-ylthio)carbapenem derivatives.
    Oh CH; Cho HW; Baek D; Cho JH
    Eur J Med Chem; 2002 Sep; 37(9):743-54. PubMed ID: 12350291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of novel 1beta-methylcarbapenems with oxyiminopyrrolidinylamide moiety.
    Lee JH; Lee KS; Kang YK; Yoo KH; Shin KJ; Kim DC; Kong JY; Lee Y; Lee SJ; Kim DJ
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4399-403. PubMed ID: 14643334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of novel 1beta-methylcarbapenems having a new moiety at C-2.
    Kang YK; Shin KJ; Yoo KH; Seo KJ; Park SY; Kim DJ; Park SW
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2385-90. PubMed ID: 10476874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel carbapenem antibiotic, SM-7338 structure-activity relationships.
    Sunagawa M; Matsumura H; Inoue T; Fukasawa M; Kato M
    J Antibiot (Tokyo); 1990 May; 43(5):519-32. PubMed ID: 2358404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antibacterial activity of 1-beta-methylcarbapenem having a 1,3-diazabicyclo[3.3.0]octan-4-one moiety.
    Nam KH; Oh CH; Cho JK; Kim HJ; Lee KS; Cho JH
    Arch Pharm (Weinheim); 1996 Oct; 329(10):443-6. PubMed ID: 8933746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial activities of 4-pyrrolidinylthio carbapenems: containing heteroaromatics as a side chain.
    Cho HW; Oh CH; Lee JS; Lee SC; Choi JH; Cho JH
    Arch Pharm (Weinheim); 2003 Nov; 336(11):495-503. PubMed ID: 14639741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in-vitro activity of new 1beta-methylcarbapenem derivatives as antibacterial agents.
    Jung MH; Hong JH; Cho JH; Oh CH
    Arch Pharm (Weinheim); 2008 Dec; 341(12):780-6. PubMed ID: 19009543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted oxadiazolo pyrrolidin-3-yl-thio)carbapenem derivatives.
    Oh CH; Dong HG; Lee JS; Lee SC; Hong JH; Cho JH
    Arch Pharm (Weinheim); 2003 Dec; 336(12):567-72. PubMed ID: 14677150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in-vitro activity of novel 1beta-methylcarbapenems having spiro[2,4]heptane moieties.
    Park HB; Jo NH; Hong JH; Choi JH; Cho JH; Yoo KH; Oh CH
    Arch Pharm (Weinheim); 2007 Oct; 340(10):530-7. PubMed ID: 17849445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel prodrugs of meropenem with two lipophilic promoieties: synthesis and pharmacokinetics.
    Tanaka S; Matsui H; Kasai M; Kunishiro K; Kakeya N; Shirahase H
    J Antibiot (Tokyo); 2011 Mar; 64(3):233-42. PubMed ID: 21224861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.